🇺🇸 FDA
Patent

US 11102961

Non-human animals having a humanized lymphocyte-activation gene 3

granted A61KA61K49/0008

Quick answer

US patent 11102961 (Non-human animals having a humanized lymphocyte-activation gene 3) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K49/0008